The Arrow Endurance System will be discussed at a Platinum Showcase titled "The New Age of Midlines and the Arrow Endurance Extended Dwell Peripheral Catheter System", presented by Nancy Moureau, BSN, RN, CRNI, CPUI, VA-BC. The event will be held Monday, Sept. 28 from 4:50 p.m. to 5:50 p.m. in room Grapevine A.

Teleflex will have the extended dwell catheter system exhibited at Booth 501 in the Exhibit Hall so attendees can have hands-on experience with the device.

The Arrow Endurance System is cleared by the FDA to dwell up to 29 days.

The Arrow Endurance System enables hospitals to avoid using multiple peripheral IVs to achieve longer dwell times while also avoiding the extra clinical risks and expenses associated with a peripherally inserted central catheter (PICC).

The Arrow Endurance Catheter is intended for short-term use (up to 29 days) to permit delivery of infusion therapies, pressure monitoring, high pressure injection (325 psi max.), and withdrawal of blood.

Teleflex’s activities at this year’s AVA will focus on clinician education, enabling non-physician inserters to insert CVCs and arterial lines, and supporting clinicians in always selecting the right line for their patients.

"There are many vital choices that must be made so a patient gets the safest, most effective IV therapy possible. Our philosophy of "Right Line. Right Patient. Right Time." helps us deliver products that align with safe patient care," said Jay White, President of the Vascular Access Division of Teleflex.

"The Arrow Endurance Catheter continues to build upon this philosophy. We look forward to launching this product at this year’s AVA meeting as well as providing an additional line-up of clinical education opportunities."

Teleflex will also have clinical education activities at its booth, where phantoms and models will be used to demonstrate the full range of the company’s vascular access devices. The company is also offering its popular Vascular Access Procedural Cadaver Lab at the meeting site.